Adma Biologics (ADMA) Free Cash Flow Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Adma Biologics | 1.90 Bn | 1.81 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.28% |
| Sep 30, 2025 | 47.42% |
| Jun 30, 2025 | 22.29% |
| Mar 31, 2025 | 1.82% |
| Dec 31, 2024 | 33.46% |
| Sep 30, 2024 | 23.89% |
| Jun 30, 2024 | 34.40% |
| Mar 31, 2024 | 20.53% |
| Dec 31, 2023 | 23.18% |
| Sep 30, 2023 | 23.55% |
| Jun 30, 2023 | 14.76% |
| Mar 31, 2023 | 0.37% |
| Dec 31, 2022 | 6.25% |
| Sep 30, 2022 | -10.08% |
| Jun 30, 2022 | -13.59% |
| Mar 31, 2022 | -39.81% |
| Dec 31, 2021 | -59.27% |
| Sep 30, 2021 | -28.14% |
| Jun 30, 2021 | -49.96% |
| Mar 31, 2021 | -47.17% |
| Mar 31, 2018 | -40.15% |
| Dec 31, 2017 | -52.84% |
| Sep 30, 2017 | -37.10% |
| Jun 30, 2017 | -53.14% |
| Mar 31, 2017 | -22.00% |
| Dec 31, 2016 | -188.02% |
| Sep 30, 2016 | -290.20% |
| Jun 30, 2016 | -55.04% |
| Mar 31, 2016 | -63.40% |